Close
Nordic 9Nordic 9

Bergens forskningsstiftelse (investor - Corporate Investor)

Norway bfstiftelse.no
See something wrong or missing? Let us know
Offices:Bergen

Bergens forskningsstiftelse (Bergen Research Foundation) gives grants toward research and research supporting activities at the University of Bergen and Haukeland University Hospital, and other Norwegian reserach institutions if they cooperate with the institutions in Bergen.  It also gives grants to support research at the University of Bergen and Haukeland University Hospital at the interface between basic research and clinical research.

Average round investment:3M USD
Average number per year:1.0
Distribution: 2019 (1)2017 (1)
Portfolio companies: Norway APIM Therapeutics
Mostly invests in: Norway Norway (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Bergens forskningsstiftelse

Name Criteria
Norway Alpine Capital AS
62%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Artal AS
62%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Sciencons
62%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
Norway Inven2
62%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.2
Norway CoFounder
62%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.2
Norway Sparebanken Vest
61%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.3
Norway Proventure Management
61%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.5
Norway Stratel AS
61%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.7
Norway Sintef TTO
60%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.2
Norway Skagerak Capital
60%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.4
Top